Introduction Metabolic dysfunction-associated steatotic liver disease has emerged as a silent epidemic in modern medicine, affecting nearly 38% of adults worldwide and poised to become the leading cause of liver transplantation by 2030. Previously known as Metabolic dysfunction-Associated Steatotic Liver disease , this rebranding in 2023 better reflects its root cause — metabolic dysfunction tied […]